NUS
Nu Skin Enterprises Inc
NYSE: NUS · CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS
$7.16
+1.99% today
Updated 2026-05-08
Market cap
$352.11M
P/E ratio
6.63
P/S ratio
0.24x
EPS (TTM)
$1.08
Dividend yield
3.42%
52W range
$6 – $14
Volume
0.5M
Nu Skin Enterprises Inc (NUS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
3.78%
Operating margin
1.83%
ROE
7.04%
ROA
3.68%
Debt/equity
0.45x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.12B | $32.82M | 82.50% | 4.90% | 2.94% |
| 2007 | $1.16B | $43.87M | 81.92% | 6.13% | 3.79% |
| 2008 | $1.25B | $65.35M | 81.68% | 10.05% | 5.24% |
| 2009 | $1.33B | $89.84M | 81.70% | 11.10% | 6.75% |
| 2010 | $1.54B | $136.05M | 82.28% | 14.12% | 8.85% |
| 2011 | $1.74B | $153.33M | 81.50% | 13.40% | 8.79% |
| 2012 | $2.17B | $221.65M | 83.72% | 15.71% | 10.22% |
| 2013 | $3.18B | $364.89M | 84.08% | 17.44% | 11.49% |
| 2014 | $2.57B | $189.18M | 81.38% | 13.71% | 7.36% |
| 2015 | $2.25B | $133.05M | 78.22% | 10.89% | 5.92% |
| 2016 | $2.21B | $143.09M | 77.33% | 10.47% | 6.48% |
| 2017 | $2.28B | $129.44M | 77.97% | 12.04% | 5.68% |
| 2018 | $2.68B | $121.89M | 76.33% | 8.99% | 4.55% |
| 2019 | $2.42B | $173.55M | 75.98% | 11.05% | 7.17% |
| 2020 | $2.58B | $191.35M | 74.51% | 9.98% | 7.41% |
| 2021 | $2.70B | $147.27M | 74.95% | 8.68% | 5.46% |
| 2022 | $2.23B | $104.78M | 71.65% | 4.98% | 4.71% |
| 2023 | $1.97B | $8.60M | 68.93% | 2.45% | 0.44% |
| 2024 | $1.73B | $-146.59M | 68.23% | -8.75% | -8.46% |
| 2025 | $1.49B | $160.20M | 69.45% | 6.12% | 10.79% |